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ABSTRACT 
Central venous catheters (CVCs) are inserted in order to administer fluids and 
medications. A peripherally inserted central catheter (PICC) is a type of CVC. While beneficial, 
central line associated bloodstream infection (CLABSI) is a risk for patients having a CVC 
inserted. Antiseptics are used for skin preparation when inserting a central line to prevent 
infection and during maintenance of the central line. Currently, the Center for Disease Control 
recommends the use of chlorhexidine for central venous catheter insertion in patients two months 
of age or older. Studies have found reduced CLABSI rates with the use of chlorhexidine for 
CVC insertion and maintenance in neonates.  Research has also found chlorhexidine to have a 
more substantial and longer lasting effect than povidone- iodine as an antiseptic. However, 
studies have also noted concerns related to skin irritation and burns in low weight neonates with 
the use of chlorhexidine. Additional research is needed to determine the efficacy of 
chlorhexidine in preventing CLABSI infections in the neonatal population.   
This study compared the CLABSI rate in a Northwest Arkansas neonatal intensive care 
unit (NICU) with the use of povidone-iodine versus chlorhexidine as the antiseptic for PICC line 
maintenance. The study examined all neonates in the NICU who had a PICC line. The data was 
analyzed using a descriptive statistics examining CLABSI with the use of povidone-iodine 
versus chlorhexidine as the antiseptic. One CLABSI occurred during the povidone-iodine 
protocol. No infection occurred during the chlorhexidine protocol. Because of the small infection 
rate during the timeframe of this study, it was concluded that both antiseptics were effective at 
preventing CLABSI in neonates with PICCs. This study was limited in scope and timeframe 
therefore more extensive research could be conducted to further examine if the new 
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chlorhexidine protocol is more effective at preventing CLABSI in the neonatal population with 
PICCs.  
 
Is chlorhexidine an effective antiseptic to prevent CLABSI for PICC line maintenance in 
the neonatal population? 
INTRODUCTION 
Central venous catheters (CVCs) are inserted when necessary to administer medications 
and intravenous fluid. The insertion of a CVC while beneficial, places the patient at risk of 
complications of a central line associated bloodstream infection (CLABSI) (Curry, Honneycutt, 
Goins, & Gilliam, 2009). According to the National Healthcare Safety Network, CLABSI occurs 
at a rate of 3.1-6.4 per 1,000 CVC days in the neonatal intensive care unit (NICU) (Edwards, et 
al, 2007).  
Antiseptics are used for skin preparation prior to CVC insertion and during maintenance 
to reduce the incidence of infection. Povidone-iodine is currently used for CVC skin preparation 
in neonatal patients. However, CLABSIs are still a major concern in the NICU. Chlorhexidine is 
a topical antiseptic solution that has clinically been shown to be a safe and effective antiseptic in 
adults and children for hand washing and preoperative skin preparation (Milstone, Passaretti & 
Peri, 2008). Currently, the CDC recommends the use of 0.5% chlorhexidine gluconate with 
alcohol for skin preparation before CVC and peripheral arterial catheter insertion and during 
dressing changes in adults and children older than two months of age. The Center for Disease 
Control (CDC) makes no recommendation for the use of chlorhexidine in infants under two 
months old (CDC, 2011). The efficacy of chlorhexidine in the reduction of CLABSIs in the 
neonatal population is in need of further research.  
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Although the CDC has not approved chlorhexidine for use in children less than 2 months 
of age, a national survey found that 61% of US NICUs are using chlorhexidine for CVC line 
insertion and maintenance. Fifty one percent of these NICUs restrict the use of chlorhexidine by 
birth weight, gestational age, or chronological age. Forty two percent restricted chlorhexidine use 
by gestational age of 28 weeks or less, 40% restricted by birth weight, 1000g or less, and 26% 
restricted by chronological age, of less than two weeks. The other 49% used chlorhexidine 
without restriction (Tamma, Aucott & Milstone, 2010). 
Chlorhexidine has been shown to be an effective antiseptic in low birth weight infants. 
One time skin cleansing with 0.25% chlorhexidine reduced colonization by 62% compared to no 
cleansing (Sankar et al., 2009).  
Research compared the efficacy of povidone-iodine and chlorhexidine. A study 
comparing the effectiveness of chlorhexidine to povidone iodine and sodium hypochlorite found 
all antiseptics were comparable for short procedures but found chlorhexidine to be the only 
antiseptic with a substantive effect, indicating that the antiseptic is effective against the 
introduction of new organisms over time. Chlorhexidine is recommended for longer procedures 
such as indwelling catheter insertion and surgery (Macias et al., 2013). However, in a pilot trial 
conducted in 2009 comparing the use of povidone-iodine (10%) to chlorhexidine gluconate (2%) 
for the insertion of CVC in neonates seven days of age or older and weighing over 1500 g, no 
statistically significant difference in infection rates between the two antiseptics was found 
(Garland et al., 2009). A study published in 2001 found the use of chlorhexidine-impregnated 
dressing and 70% alcohol scrub to be as effective as 10% povidone iodine in preventing CRBSI 
(catheter related bloodstream infection) and BSI (bloodstream infection) in neonates (Garland et 
al., 2001). 
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Chlorhexidine is not currently recommended for use in neonates less than 2 months of 
age due to concerns related to skin integrity. A study in a NICU found severe contact dermatitis 
in very low birth weight infants with the use of chlorhexidine gluconate impregnated patches.  
The trial continued excluding infants less than 800g or less than 7 days old and found only three 
reactions of the remaining 75 participants (Garland, Alex, Mueller & Cisler-Kahill, 1996). 
Garland and coworker’s study (2001) found contact dermatitis only in neonates under 1000g 
with use of Chlorhexidine impregnated dressings. A more recent study comparing provodine-
Iodine to chlorhexidine gluconate did not find any contact dermatitis with the use of 
chlorhexidine gluconate in neonates over 1500g. The study did result in a case of contact 
dermatitis with the use of povidone iodine (Garland et al., 2009). One time skin cleansing with 
0.25% chlorhexidine did not cause adverse skin effect or induce hypothermia in neonates 1001-
2000g (Sankar et al., 2009). In a national survey of NICUs, 17 of the participating NICUs 
reported burns from using chlorhexidine in which 13 of the cases were in neonates less than 
1500g (Tamma, Aucott & Milstone, 2010). 
Another concern related to the use of chlorhexidine in neonates is absorption of the 
antiseptic into the bloodstream. A study comparing provodine-iodine to chlorhexidine gluconate 
found that chlorhexidine gluconate was absorbed into the bloodstream of the neonates. However, 
no significant side effects were reported in the trial (Garland et al., 2009). 
Studies have found implementation of central line bundles in the NICU, including the use 
of chlorhexidine as an antiseptic; have shown a statistically significant decrease in the number of 
CLABSI infections (Schulman et al., 2011; Miller et al., 2011). Bundles are evidence-based 
practices implemented as a group, at the same time, in a clinical setting (Butler-O’Hara, 
D’Angio, Hoey & Stevens, 2012).  These bundles provide protocol for central line insertion and 
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site maintenance. A New York statewide implementation of a bundle including chlorhexidine 
resulted in a 67% CLABSI rate decrease statewide (Schulman et al., 2011). Another study 
implemented the use of chlorhexidine in all CVC catheter types in the NICU, which resulted in a 
decrease in CLABSI infection rates among all catheter types and birth weight neonates (Sannoh, 
Clones, Munoz, Montecalvo & Parvez, 2010).  
A study completed by Arkansas Children’s hospital examined the impact of the 
implementation of a CVC site bundle consisting of best practice measures to reduce CLABSI. 
The bundle included the use of chlorhexidine and alcohol as a skin antiseptic, and a 
chlorhexidine impregnated patch around the catheter insertion site. This study included infants 
greater than 2000g or who were greater than two weeks old. A substantial reduction in infection 
rates from 4.9 infections per 1000 catheter days in 2005 to 2.1 infections per 1000 catheter days 
in 2007 occurred despite an overall 40% increase in total line days (Curry, Honeycutt, Goins, & 
Gillam, 2009). A similar three year study of 29 pediatric intensive care units (PICUs) 
demonstrated a 56% decrease in the rate of CLABSI infections after bundle implementation 
(Miller et al., 2011). 
Further research is needed to determine the efficacy of chlorhexidine as an antiseptic in 
neonates. Although concerns exist related to skin integrity, more recent studies have not resulted 
in skin integrity issues. Bloodstream absorption of chlorhexidine is also a concern, but negative 
side effects related to absorption have not been documented. Chlorhexidine has been shown to be 
an effective antiseptic in both adults and children and implementation of bundles including the 
use of chlorhexidine in the NICU have been successful in the reduction of CLABSIs.   
AIMS 
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The aim of this study will be to compare CLABSI rates in a Northwest Arkansas NICU 
with use of povidone-iodine as an antiseptic to the rates of CLABSI following implementation of 
a standard protocol using chlorhexidine for PICC line site maintenance.   
Variables. The independent variables are the antiseptics used to maintain PICC lines, 
povidone and chlorhexidine, and the dependent variable is the CLABSI rate.  
METHODS   
 Design.  A quasi-experimental study design using a pre- post design with two comparison 
treatments was used in this study. This study used a retrospective chart review to evaluate the 
variables.   
Purposive sampling was used in this study. The sample included neonates receiving a 
PICC line placement during the determined study period. The first group in the study consisted 
of neonates admitted to the NICU between August-November 2012 who had a PICC line 
inserted for greater than 24 hours and received the povidone-iodine protocol. The second group 
consisted of neonates admitted to the NICU between August-November 2013 who had a PICC 
line inserted for greater than 24 hours who received the chlorhexidine protocol.  
Procedure. Prior to data collection, approval was obtained from the University of 
Arkansas Institutional Review Board (IRB) and the Quality Improvement Department of study 
hospital. Data was then collected from comparable time periods before the new protocol was 
implemented and after implementation. Retroactive chart audits of all infants meeting the study 
criteria were reviewed for CLABSI. Additional data including gestational age, birth weight, age 
at time of PICC insertion, weight at time of PICC insertion, age at time of PICC removal, weight 
at time of PICC removal, and length of time PICC was in use was collected. All data was de-
identified.  
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RESULTS 
Table 1  
PICC inserted in the NICU during the 2012 Povidone-Iodine Protocol 
Patient 
Number 
Gestational 
Age 
Birth 
weight 
Age at 
PICC 
insertion 
Weight 
at PICC 
insertion 
Age at 
PICC 
removal 
Weight 
at PICC 
removal 
Duration 
of PICC CLABSI  
1 28 4/7 weeks 1090g 9 days 1220g 30 days 1800g 21 days Positive 
2 27 weeks 1080g 7 days 950g 31 days 1481g 24 days Negative 
3 34 1/7 weeks 2195g 2 days 2105g 8 days 2085g 6 days Negative 
4 32 weeks 1210g 8 days 1197g 22 days 1610g 14 days Negative 
5 34 1/7 weeks 2204g 1 day 2215g 8 days 2080g 7 days Negative 
6 35 6/7 weeks 3090g 5 days 2900g 9 days 3150g 4 days Negative 
7 32 6/7 2226g 2 days 2063g 25 days 2788g 23 days Negative 
 
Table 2  
PICC inserted in the NICU during the 2013 Chlorhexidine Protocol 
Patient 
Number  
Gestational 
Age 
Birth 
weight 
Age at 
PICC 
insertion 
Weight 
at PICC 
insertion 
Age at 
PICC 
removal 
Weight 
at PICC 
removal 
Duration 
of PICC CLABSI 
1 35 1/7 weeks 2537g 2 days 2565 7 days 2548 g 5 days Negative 
2 33 weeks 1840g 2 days 1690g 9 days 1810g 7 days Negative 
3 33 weeks 2015g 10 days 2000g 24 days 2561g 14 days Negative 
4 37 4/7 weeks 2460g 6 days 2490g N/A N/A N/A N/A 
5 31 5/7 weeks 1735g 4 days 1648g 12 days 2079g 8 days Negative 
6 31 5/7 weeks 1570g 2 days 1518g 18 days 1739g 16 days Negative 
7 32 1/7 weeks 1625g 0 days 1625g 8 days 1613g 8 days Negative 
8 29 weeks 1245g  7 days 1170g 14 days 2178g 7 days Negative 
9 33 weeks 2010g 1 day 1940g 7 days 2045g 6 days Negative 
10 34 1/7 weeks 1510g 4 days 1438g 14 days 1668g 10 days Negative 
11 38 weeks 2983g 3 days 2880g 7 days 2835g 4 days Negative 
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Data was analyzed using descriptive analysis. The data from the povidone-iodine 
protocol was compared to that under the chlorhexidine protocol regarding CLABSI rates, 
gestational age, birth weight, age at time of PICC insertion, weight at time of PICC insertion, age 
at time of PICC removal, weight at time of PICC removal, and length of time PICC was in use. 
Under the povidone-iodine protocol between August and October 2012 seven PICC lines 
were inserted (Table 1). The gestational ages of the infants with PICC lines ranged from 27 to 35 
6/7 weeks with an average gestational age of 32.07 weeks (Table 1). The birth weight of the 
infants ranged from 1080g to 3090g with an average of 1870g (Table 1). The age at time of 
insertion of the PICC line ranged from 1 to 9 days with an average of 4.85 days (Table 1). The 
infant weight at time of insertion of the PICC ranged from 950g to 2900g with an average of 
1807.1g (Table 1). The age ranges on removal of the PICC was 8 to 31 days with an average 
time of 19 days (Table 1). The weight at time of PICC removal ranged from 1481g to 3150g with 
an average of 2142g (Table 1). The range PICC line duration was 4 to 24 days with an average of 
14.1 days (Table 1).   Under the chlorhexidine protocol between August and October 2013 
eleven PICC lines were inserted (Table 2). The gestational ages of the infants with PICC lines 
ranged from 31 5/7 to 38 weeks with an average gestational age of 33.5 weeks (Table 2). The 
birth weight of the infants ranged from 1510g to 2983g with an average of 1957.3g (Table 2). 
The age at time of insertion of the PICC line ranged from 0 to 10 with an average of 3.7 days 
(Table 2). The infant weight at time of insertion of the PICC ranged from 1170g to 2880g with 
an average of 1905.8g  (Table 2). The age ranges on removal of the PICC was 7 to 24 days with 
an average of 12 days (Table 2). The weight at time of PICC removal ranged from 1613g to 
2835g with an average of 2107.6g (Table 2). The range PICC line duration was 4 to 16 days with 
an average time of 8.5 days (Table 2).  
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Of the data collected one CLABSI infection occurred.  This infection occurred under the 
previous povidone-iodine protocol in October 2012. The infection occurred in an infant born in 
October 2012 who was 28 weeks gestation with a birth weight of 1090 grams. The infant was 9 
days old upon insertion of the PICC line and weighed 1220g. The line blood cultures tested 
positive for staphylococcus epidermis 19 and 21 days later. The PICC line was removed on day 
21 when the infant was 30 days old and weighed 1800g. 
DISCUSSION 
 In comparing the CLABSI rate under the previous Povidone-Iodine protocol and the new 
chlorhexidine protocol minimal infection occurred. Only one CLABSI occurred under the 
Povidone-Iodine protocol. While the infection rate was not significant at this facility, any 
infection should be treated as a critical incident. That being said from the data collected, a 
definite conclusion cannot be drawn as to if chlorhexidine is a more effective antiseptic than 
povidone-iodine, however the data shows both antiseptics to be effective at preventing CLABSI 
based on the low infection rates under both protocols.  
The study was limited because the new chlorhexidine protocol was not fully implemented 
to include chlorhexidine use on the skin during PICC line insertion. This study was also limited 
in the scope and timeframe of data that could be included in the study. For neonate 4 under the 
chlorhexidine protocol only part of the information could be obtained because the neonate was 
transferred to a different hospital for care.  
CONCLUSION 
Based on the data collected this facility’s former and current protocols were both 
effective at preventing CLABSI in neonates with PICCs. This study was limited in its scope of 
data and timeframe that could be included. A larger more extensive study could be conducted to 
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determine if both antiseptics prove to be equally effective at preventing CLABSI in neonates 
with PICCs.  
 Research could also be conducted at this facility to determine employee compliance with 
the new protocol to define what factors were most effective at preventing infection. Employee 
compliance with documentation of PICC insertion, maintenance, and removal could also be 
examined for improved standardization of documentation.  
Further research should also be done at this facility after the new chlorhexidine protocol 
is expanded to include skin contact with Chlorhexidine. During this study chlorhexidine use on 
the skin was not implemented as part of the protocol. Research including the use of 
chlorhexidine on the skin is needed to examine concerns related to the use of chlorhexidine in 
neonates and skin integrity. Additional and more extensive research studies are needed to 
develop standard restrictions based on age and weight for chlorhexidine skin contact with 
neonates due to previous research conveying concerns related to skin integrity.  
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